These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 21959309)
1. Claudin-5 as an immunohistochemical marker for angiosarcoma and hemangioendotheliomas. Miettinen M; Sarlomo-Rikala M; Wang ZF Am J Surg Pathol; 2011 Dec; 35(12):1848-56. PubMed ID: 21959309 [TBL] [Abstract][Full Text] [Related]
2. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors. Miettinen M; Wang ZF Am J Surg Pathol; 2012 Mar; 36(3):351-9. PubMed ID: 22067331 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors. Miettinen M; Rikala MS; Rys J; Lasota J; Wang ZF Am J Surg Pathol; 2012 Apr; 36(4):629-39. PubMed ID: 22314185 [TBL] [Abstract][Full Text] [Related]
4. Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: implications in tumor diagnosis. Miettinen M; Fetsch JF Hum Pathol; 2000 Sep; 31(9):1062-7. PubMed ID: 11014572 [TBL] [Abstract][Full Text] [Related]
5. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit. Miettinen M; Sarlomo-Rikala M; Lasota J Mod Pathol; 2000 May; 13(5):536-41. PubMed ID: 10824925 [TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Folpe AL; Veikkola T; Valtola R; Weiss SW Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276 [TBL] [Abstract][Full Text] [Related]
7. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Partanen TA; Alitalo K; Miettinen M Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384 [TBL] [Abstract][Full Text] [Related]
8. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Folpe AL; Chand EM; Goldblum JR; Weiss SW Am J Surg Pathol; 2001 Aug; 25(8):1061-6. PubMed ID: 11474291 [TBL] [Abstract][Full Text] [Related]
9. Keratin 1 expression in endothelia and mesenchymal tumors: an immunohistochemical analysis of normal and neoplastic tissues. Remotti F; Fetsch JF; Miettinen M Hum Pathol; 2001 Aug; 32(8):873-9. PubMed ID: 11521233 [TBL] [Abstract][Full Text] [Related]
10. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Rossi S; Orvieto E; Furlanetto A; Laurino L; Ninfo V; Dei Tos AP Mod Pathol; 2004 May; 17(5):547-52. PubMed ID: 15001993 [TBL] [Abstract][Full Text] [Related]
11. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma. Hung YP; Fletcher CD; Hornick JL Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608 [TBL] [Abstract][Full Text] [Related]
12. Frequent expression of conventional endothelial markers in pleural mesothelioma: usefulness of claudin-5 as well as combined traditional markers to distinguish mesothelioma from angiosarcoma. Nakashima Y; Inamura K; Ninomiya H; Okumura S; Mun M; Kirimura S; Kobayashi M; Okubo K; Ishikawa Y Lung Cancer; 2020 Oct; 148():20-27. PubMed ID: 32777673 [TBL] [Abstract][Full Text] [Related]
13. ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma. Miettinen M; Wang ZF; Paetau A; Tan SH; Dobi A; Srivastava S; Sesterhenn I Am J Surg Pathol; 2011 Mar; 35(3):432-41. PubMed ID: 21317715 [TBL] [Abstract][Full Text] [Related]
14. ERG expression in epithelioid sarcoma: a diagnostic pitfall. Miettinen M; Wang Z; Sarlomo-Rikala M; Abdullaev Z; Pack SD; Fetsch JF Am J Surg Pathol; 2013 Oct; 37(10):1580-5. PubMed ID: 23774169 [TBL] [Abstract][Full Text] [Related]
15. B72.3 and CD34 immunoreactivity in malignant epithelioid soft tissue tumors. Adjuncts in the recognition of endothelial neoplasms. Sirgi KE; Wick MR; Swanson PE Am J Surg Pathol; 1993 Feb; 17(2):179-85. PubMed ID: 7678485 [TBL] [Abstract][Full Text] [Related]
16. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors. Xu H; Edwards JR; Espinosa O; Banerji S; Jackson DG; Athanasou NA Hum Pathol; 2004 Jul; 35(7):857-61. PubMed ID: 15257549 [TBL] [Abstract][Full Text] [Related]
17. Claudin-5 protein is a new differential marker for histopathological differential diagnosis of canine hemangiosarcoma. Jakab C; Halász J; Kiss A; Schaff Z; Rusvai M; Gálfi P; Abonyi TZ; Kulka J Histol Histopathol; 2009 Jul; 24(7):801-13. PubMed ID: 19475526 [TBL] [Abstract][Full Text] [Related]
18. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Breiteneder-Geleff S; Soleiman A; Kowalski H; Horvat R; Amann G; Kriehuber E; Diem K; Weninger W; Tschachler E; Alitalo K; Kerjaschki D Am J Pathol; 1999 Feb; 154(2):385-94. PubMed ID: 10027397 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Vascular Markers (Immunohistochemical Stains) in Soft Tissue Sarcomas. Naeem N; Mushtaq S; Akhter N; Hussain M; Hassan U J Coll Physicians Surg Pak; 2018 May; 28(5):352-356. PubMed ID: 29690962 [TBL] [Abstract][Full Text] [Related]
20. Expression of claudin-1 in canine peripheral nerve sheath tumours and perivascular wall tumours. Immunohistochemical study. Jakab C; Gálfi P; Jerzsele Á; Szabó Z; Németh T; Sterczer Á; Rusvai M; Ózsvári L Histol Histopathol; 2012 Jul; 27(7):905-17. PubMed ID: 22648546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]